SV Biotech Crossover Opportunities Fund LP
Form D Filings
Location
London, United Kingdom
Investment Fund Type
Venture Capital Fund
Industry Group
Pooled Investment Fund
Related People
SV BCO I GP LLP
,
SV Health Managers LLP
,
Houman Ashrafian
,
Kate Bingham
,
Nicola Trbovic
Entity Type
Limited Partnership
CIK
0001903934
All SEC Filings
View on sec.gov
Date Filed
Security Types
Total Amount Sold
Total Offering
Amount Remaining
First Sale
Signed
Form
SEC Link
1/18/2022
Equity, Pooled Investment Fund
$135,180,000
$350,000,000
$214,820,000
12/31/2021
1/18/2022
D
000190393422000001